The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to new anticancer agents based on the miliusane compounds. The present invention also includes its preparation and application method for treating cancer
[更多]
TEC Edmonton is seeking licensing partners for a novel precursor that simplifies synthesis of [18F]FAZA, a PET radiotracer that selectively accumulates in hypoxic cells. It was invented and developed at the Cross Cancer Institute of Alberta and is currently used in several medical centers to assess .....
[更多]
TEC Edmonton is seeking collaborative development and licensing partners for a novel PET imaging agent. Dr. Chris Cheeseman and colleagues at the University of Alberta have recently designed and synthesized a new class of fluorinated fructose compounds with the potential to be used during in vivo P.....
[更多]
This invention introduces a new method of using an anthraquinone derivative or known as Rhein, for treating chronic pancreatitis. It is notably that Rhein or extracts from Polygonaceae (rhubarb) is a potential anti-fibrotic agent without giving any adverse effects in the animal study. Most important.....
[更多]
dl-THP (dl-tetrahydropalinatine) was only marketed as an herbal supplement or sleeping pill. However, a novel use of dl-THP is available now.The present invention succeeds in identifying a previously unsuggested binding partner for dl-THP, namely the BDZ (benzodiazepine) binding site of the GABAA re.....
[更多]
| |< <- | [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] | -> >| |
